Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat

被引:42
作者
Blaauw, Y. [1 ]
Schotten, U. [1 ]
van Hunnik, A. [1 ]
Neuberger, H. R. [1 ]
Allessie, M. A. [1 ]
机构
[1] Maastricht Univ, Dept Physiol, CARIM, NL-6200 MD Maastricht, Netherlands
关键词
antiarrhythmia agents; electrophysiology; atrial fibrillation; K-channel;
D O I
10.1016/j.cardiores.2007.03.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In electrically remodeled atria the effect of blockers of the delayed rectifier K+ current I-Kr on repolarization is reduced, whereas the efficacy of 'early' class III drugs (I-kur/I-to/I-Kach blockers) is enhanced. We evaluated the electrophysiological and antifibrillatory effects of AVE0118, dofetilide, and ibutilide (alone and in combination) on persistent atrial fibrillation (AF) in the goat. Methods and results: The effects of separate and combined administration of AVE0118, dofetilide, and ibutilide were determined before and after 48 h of AF. AVE0118 alone markedly prolonged the atrial refractory period (400 ms cycle length) (AERP(400)) before and after 48 h of AF. The prolongation of AERP(400) by dofetilide and ibutilide, respectively, was reduced by AT from 22 +/- 2 to 7 +/- 2 ms (p < 0.01) and 25 +/- 5 to 5 +/- 2 ms (p=0.01). Pre-treatment with AVE0118 restored the prolongation of AERP(400) by dofetilide or ibutilide (to 20 +/- 3 and 30 +/- 6 ms; p < 0.0 1). This effect was atrial specific since the QT-interval was not changed. The antifibrillatory action was evaluated in 10 goats that were in persistent AF for 57 +/- 7 days. Dofetilide (20 mu g/kg/h) or ibutilide (4 mg/h) alone restored sinus rhythm in only 20% of the animals. AVE0118 (1, 3, and 10 mu g/kg/h) terminated AF in 11, 30, and 60%, respectively. Additional infusion of I-Kr blockers caused an additional number of cardioversions, resulting in a final cardioversion rate of 56, 80, and 100%, respectively. AVE0118 alone prolonged the AF cycle length (AFCL) while the conduction velocity during AF (CVAF) remained unchanged (70 +/- 1 vs. 68 +/- 2 cm/s;p=0.3). Addition of dofetilide or ibutilide caused a synergistic increase in AFCL and a slight increase in CVAF to 74 +/- 1 cm/s (p < 0.001). The length of the reentrant trajectories increased from 7.6 +/- 0.3 (control) to 11.6 +/- 0.5 Pm after AVE0118 alone (p < 0.001) and 14.8 +/- 0.8 cm after addition of dofetilide or ibutilide (p < 0.001). Conclusions: In electrically remodeled atria, blockade of I-Kur/I-to/I-KAch restored the class III action Of I-Kr blockers. Persistent AF could be effectively cardioverted by infusion of a combination of AVE0118 and dofetilide or ibutilide. This antifibrillatory action was associated with an almost twofold lengthening of the intra-atrial pathways for reentry. (c) 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 26 条
[1]   Early class III drugs for the treatment of atrial fibrillation -: Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat [J].
Blaauw, Y ;
Gögelein, H ;
Tieleman, RG ;
van Hunnik, A ;
Schotten, U ;
Allessie, MA .
CIRCULATION, 2004, 110 (13) :1717-1724
[2]   Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model [J].
Courtemanche, M ;
Ramirez, RJ ;
Nattel, S .
CARDIOVASCULAR RESEARCH, 1999, 42 (02) :477-489
[3]   Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009 [J].
Crijns, Harry J. ;
Van Gelder, Isabele C. ;
Walfridsson, Hakan ;
Kulakowski, Piotr ;
Ronaszeki, Aladar ;
Dedek, Vratislav ;
Malm, Anders ;
Almgren, Olle .
HEART RHYTHM, 2006, 3 (11) :1321-1331
[4]   Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs [J].
Duytschaever, A ;
Blaauw, Y ;
Allessie, A .
CARDIOVASCULAR RESEARCH, 2005, 67 (01) :69-76
[5]   The mechanism of atrial antiarrhythmic action of RSD1235 [J].
Fedida, D ;
Orth, PMR ;
Chen, JYC ;
Lin, SP ;
Plouvier, B ;
Jung, G ;
Ezrin, AM ;
Beatch, GN .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (11) :1227-1238
[6]   Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels [J].
Gögelein, H ;
Brendell, J ;
Steinmeyer, K ;
Strübing, C ;
Picard, N ;
Rampe, D ;
Kopp, K ;
Busch, AE ;
Bleich, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (03) :183-192
[7]   AZD7009: A new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model [J].
Goldstein, RN ;
Khrestian, C ;
Carlsson, L ;
Waldo, AL .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (12) :1444-1450
[8]   Automatic mapping of human atrial fibrillation by template matching [J].
Houben, Richard P. M. ;
de Groot, Natasja M. S. ;
Lindemans, Fred W. ;
Allessie, Maurits A. .
HEART RHYTHM, 2006, 3 (10) :1221-1228
[9]   4-AMINOPYRIDINE AND THE EARLY OUTWARD CURRENT OF SHEEP CARDIAC PURKINJE-FIBERS [J].
KENYON, JL ;
GIBBONS, WR .
JOURNAL OF GENERAL PHYSIOLOGY, 1979, 73 (02) :139-157
[10]   Evidence for two components of delayed rectifier K+ current in human ventricular myocytes [J].
Li, GR ;
Feng, JL ;
Yue, LX ;
Carrier, M ;
Nattel, S .
CIRCULATION RESEARCH, 1996, 78 (04) :689-696